Key result
Pre-eclampsia without proteinuria was associated with similar rates of composite maternal complications (20% vs 15.1%) and neonatal complications (13.3% vs 17%) compared to pre-eclampsia with proteinuria.
Why the study?
To investigate whether pregnancy outcomes differ based on the presence of proteinuria and validate the adoption of revised ISSHP diagnostic criteria for pre-eclampsia in Japan.
Does pre-eclampsia without proteinuria lead to different pregnancy outcomes compared to pre-eclampsia with proteinuria in women with hypertensive disorders of pregnancy?
Cohort (n=308)
No
Does pre-eclampsia without proteinuria lead to different pregnancy outcomes compared to pre-eclampsia with proteinuria in women with hypertensive disorders of pregnancy?
Pregnancy outcomes for pre-eclampsia with and without proteinuria are similar, supporting the adoption of the ISSHP diagnostic criteria in Japan.
Supports equivalent vigilance for pre-eclampsia regardless of proteinuria; leaves open prospective validation of ISSHP criteria.
AIMS: The Japanese Society for the Study of Hypertension in Pregnancy revised the diagnostic criteria for pre-eclampsia (PE) to conform to those of the International Society for the Study of Hypertension in Pregnancy (ISSHP) in 2018. This study aimed to investigate whether pregnancy outcomes differ based on the presence of proteinuria and validate the adoption of the ISSHP criteria in Japan. METHODS: This is a retrospective study involving 308 women diagnosed with hypertensive disorders of pregnancy at a tertiary center. They were divided into the following groups: PE with proteinuria (n = 218), PE without proteinuria (n = 45) and gestational hypertension (n = 45) according to the ISSHP criteria for comparison of pregnancy outcomes. RESULTS: Applying the ISSHP criteria increased the number of pregnant women diagnosed as having PE by 14.6% (45 women). The difference in the rate of composite maternal complications between the two groups was unremarkable, with 33 cases (15.1%) in the PE with proteinuria group and 9 cases (20%) in the PE without proteinuria group. Moreover, composite neonatal complications occurred in 37 cases (17%) of PE with proteinuria group and 6 cases (13.3%) of PE without proteinuria group, showing remarkably similar incidence rate in the two groups. Women with PE with and without proteinuria had significantly earlier deliveries and lower neonatal birth weight than those with gestational hypertension. CONCLUSION: Pregnancy outcomes of PE with and without proteinuria were almost similar although their incidence increased, confirming its validity for adaptation of the ISSHP criteria in Japan.
No takes yet. Share an insight, caveat, or question.
Tochio et al. (2019) conducted a cohort in Hypertensive disorders of pregnancy (n=308). Pre-eclampsia without proteinuria vs. Pre-eclampsia with proteinuria was evaluated on Composite maternal complications. Pre-eclampsia without proteinuria was associated with similar rates of composite maternal complications (20% vs 15.1%) and neonatal complications (13.3% vs 17%) compared to pre-eclampsia with proteinuria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: